Share Price and Basic Stock Data
Last Updated: November 26, 2025, 7:28 pm
| PEG Ratio | 0.00 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Elango Industries Ltd operates within the steel alloys and special steel sector, with its stock currently priced at ₹11.4 and a market capitalization of ₹4.37 Cr. Over the years, the company has experienced fluctuating revenue figures, reporting zero sales from March 2023 until June 2023, when it recorded sales of ₹1.93 lakh. Subsequently, sales declined again, with ₹0.65 lakh reported in December 2023. The trailing twelve months (TTM) sales stood at ₹1.15 Cr, reflecting a challenging operational environment. Historically, the company has struggled to maintain consistent revenue streams, with the highest revenue recorded at ₹0.55 Cr in March 2022. This inconsistency highlights the volatility in its business operations and raises concerns about its ability to generate sustainable revenues going forward.
Profitability and Efficiency Metrics
Profitability metrics for Elango Industries Ltd indicate persistent challenges. The operating profit margin (OPM) reported a negative figure of -23.81% for the trailing twelve months, signaling substantial operational inefficiencies. The net profit has consistently remained negative, with the latest figure for March 2025 recorded at -₹0.56 per share, down from -₹0.38 in March 2024. The company’s return on equity (ROE) and return on capital employed (ROCE) both stood at 5.67%, indicating a lack of effective capital utilization. Efficiency metrics also reveal concerning trends, with a cash conversion cycle of 3.80 days, which, while relatively short, does not compensate for the ongoing operational losses. These profitability and efficiency challenges pose significant risks to the company’s long-term viability and growth prospects.
Balance Sheet Strength and Financial Ratios
Elango Industries Ltd’s balance sheet reflects a precarious financial position. With no reported borrowings, the company appears to have minimal debt liabilities. However, the lack of reserves and the reported price-to-book value (P/BV) ratio of 0.98x suggest that the market is valuing the company close to its book value, which may indicate skepticism regarding future growth. Key financial ratios such as the current ratio and quick ratio stood at 3.69, which indicates adequate liquidity in the short term. However, the negative earnings yield of -0.05 and the declining book value per share from ₹12.39 in March 2021 to ₹9.87 in March 2025 highlight underlying financial weaknesses. The overall financial health of the company appears to be under strain, exacerbating concerns for potential investors.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Elango Industries Ltd shows a stable distribution, with promoters holding 35.20% of the shares, while the public holds 64.79%. This distribution reflects a healthy level of public participation, which may indicate some degree of investor confidence despite the company’s operational challenges. The number of shareholders has fluctuated slightly, with a total of 8,621 as of March 2025, indicating sustained interest in the company among retail investors. However, the absence of foreign institutional investors (FIIs) and domestic institutional investors (DIIs) suggests a lack of confidence from larger institutional players, which could impact the stock’s liquidity and market perception. The stability in promoter holding over the reported periods may provide some reassurance to investors, yet the overall investor sentiment is likely tempered by the company’s ongoing financial struggles.
Outlook, Risks, and Final Insight
The outlook for Elango Industries Ltd is fraught with both risks and potential opportunities. On one hand, the company’s ability to generate consistent revenue remains questionable, with reported sales trends indicating volatility. The persistent negative profitability margins and low ROE raise concerns about its operational efficiency and overall business model. On the other hand, the absence of debt could be seen as a strength, providing the company with some flexibility to navigate through turbulent market conditions. Moving forward, Elango Industries Ltd must focus on improving operational efficiency, enhancing revenue generation capabilities, and restoring investor confidence. Potential scenarios include a turnaround through strategic operational changes or continued struggles leading to further financial deterioration. The company’s future hinges on its ability to adapt to market demands while managing existing challenges effectively.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Elango Industries Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Elango Industries Ltd | 4.58 Cr. | 12.0 | 16.1/8.45 | 9.72 | 0.00 % | 5.67 % | 5.67 % | 10.0 | |
| Ashnisha Industries Ltd | 74.8 Cr. | 2.82 | 4.94/2.57 | 258 | 2.30 | 0.00 % | 1.23 % | 0.28 % | 1.00 |
| Usha Martin Ltd | 12,906 Cr. | 424 | 498/279 | 30.6 | 97.3 | 0.70 % | 18.8 % | 15.8 % | 1.00 |
| Shah Alloys Ltd | 152 Cr. | 77.0 | 83.8/43.3 | 5.18 | 0.00 % | 25.8 % | 1,108 % | 10.0 | |
| Mukand Ltd | 1,920 Cr. | 133 | 162/84.4 | 29.7 | 66.3 | 1.51 % | 9.91 % | 7.84 % | 10.0 |
| Industry Average | 19,476.25 Cr | 235.47 | 85.28 | 66.63 | 0.43% | 13.27% | 192.30% | 5.67 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.00 | 0.00 | 0.00 | 0.00 | 1.93 | 0.00 | 0.65 | 0.00 | 0.04 | 0.00 | 0.90 | 0.01 | 0.21 |
| Expenses | 0.07 | 0.03 | 0.04 | 0.04 | 1.93 | 0.04 | 0.67 | 0.08 | 0.13 | 0.03 | 0.93 | 0.06 | 0.26 |
| Operating Profit | -0.07 | -0.03 | -0.04 | -0.04 | 0.00 | -0.04 | -0.02 | -0.08 | -0.09 | -0.03 | -0.03 | -0.05 | -0.05 |
| OPM % | 0.00% | -3.08% | -225.00% | -3.33% | -500.00% | -23.81% | |||||||
| Other Income | 0.02 | 0.01 | 0.01 | 0.02 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.00 | 0.01 | 0.01 | 0.00 | 0.01 | 0.00 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | -0.05 | -0.03 | -0.04 | -0.02 | 0.00 | -0.04 | -0.03 | -0.09 | -0.09 | -0.03 | -0.03 | -0.05 | -0.05 |
| Tax % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | |
| Net Profit | -0.05 | -0.03 | -0.04 | -0.03 | 0.00 | -0.04 | -0.02 | -0.08 | -0.10 | -0.03 | -0.03 | -0.06 | -0.05 |
| EPS in Rs | -0.13 | -0.08 | -0.10 | -0.08 | 0.00 | -0.10 | -0.05 | -0.21 | -0.26 | -0.08 | -0.08 | -0.16 | -0.13 |
Last Updated: August 19, 2025, 7:30 pm
Below is a detailed analysis of the quarterly data for Elango Industries Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 0.21 Cr.. The value appears strong and on an upward trend. It has increased from 0.01 Cr. (Mar 2025) to 0.21 Cr., marking an increase of 0.20 Cr..
- For Expenses, as of Jun 2025, the value is 0.26 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.06 Cr. (Mar 2025) to 0.26 Cr., marking an increase of 0.20 Cr..
- For Operating Profit, as of Jun 2025, the value is -0.05 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded -0.05 Cr..
- For OPM %, as of Jun 2025, the value is -23.81%. The value appears strong and on an upward trend. It has increased from -500.00% (Mar 2025) to -23.81%, marking an increase of 476.19%.
- For Other Income, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Interest, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Depreciation, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Profit before tax, as of Jun 2025, the value is -0.05 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded -0.05 Cr..
- For Tax %, as of Jun 2025, the value is 0.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00%.
- For Net Profit, as of Jun 2025, the value is -0.05 Cr.. The value appears strong and on an upward trend. It has increased from -0.06 Cr. (Mar 2025) to -0.05 Cr., marking an increase of 0.01 Cr..
- For EPS in Rs, as of Jun 2025, the value is -0.13. The value appears strong and on an upward trend. It has increased from -0.16 (Mar 2025) to -0.13, marking an increase of 0.03.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: November 15, 2025, 3:26 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.00 | 0.00 | 0.29 | 0.48 | 0.51 | 0.20 | 0.15 | 0.25 | 0.55 | 0.00 | 2.58 | 0.96 | 1.15 |
| Expenses | 0.24 | 0.75 | 0.30 | 0.27 | 0.59 | 0.43 | 0.11 | 0.31 | 1.08 | 0.17 | 2.71 | 1.16 | 1.29 |
| Operating Profit | -0.24 | -0.75 | -0.01 | 0.21 | -0.08 | -0.23 | 0.04 | -0.06 | -0.53 | -0.17 | -0.13 | -0.20 | -0.14 |
| OPM % | -3.45% | 43.75% | -15.69% | -115.00% | 26.67% | -24.00% | -96.36% | -5.04% | -20.83% | -12.17% | |||
| Other Income | 0.15 | 0.00 | 0.61 | 0.01 | 0.01 | 0.00 | 0.00 | 0.11 | 0.11 | 0.05 | 0.01 | 0.00 | 0.00 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.03 | 0.02 | 0.02 | 0.02 | 0.00 |
| Profit before tax | -0.11 | -0.75 | 0.60 | 0.22 | -0.07 | -0.23 | 0.04 | 0.05 | -0.45 | -0.14 | -0.14 | -0.22 | -0.14 |
| Tax % | 0.00% | 0.00% | 0.00% | 18.18% | 0.00% | 0.00% | 0.00% | 20.00% | 0.00% | 0.00% | 7.14% | 0.00% | |
| Net Profit | -0.10 | -0.75 | 0.60 | 0.18 | -0.07 | -0.23 | 0.04 | 0.04 | -0.45 | -0.15 | -0.14 | -0.22 | -0.15 |
| EPS in Rs | -0.26 | -1.97 | 1.57 | 0.47 | -0.18 | -0.60 | 0.10 | 0.10 | -1.18 | -0.39 | -0.37 | -0.58 | -0.40 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -650.00% | 180.00% | -70.00% | -138.89% | -228.57% | 117.39% | 0.00% | -1225.00% | 66.67% | 6.67% | -57.14% |
| Change in YoY Net Profit Growth (%) | 0.00% | 830.00% | -250.00% | -68.89% | -89.68% | 345.96% | -117.39% | -1225.00% | 1291.67% | -60.00% | -63.81% |
Elango Industries Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 45% |
| 3 Years: | 20% |
| TTM: | 62% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 5% |
| 5 Years: | % |
| 3 Years: | 15% |
| TTM: | 29% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 6% |
| 5 Years: | 33% |
| 3 Years: | 13% |
| 1 Year: | -15% |
| Return on Equity | |
|---|---|
| 10 Years: | -1% |
| 5 Years: | -4% |
| 3 Years: | -4% |
| Last Year: | -6% |
Last Updated: September 5, 2025, 3:21 pm
No data available for the Balance Sheet data table.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 37.76 | 0.00 | 393.63 | 1,387.00 | 1,849.33 | 116.80 | 0.00 | 0.00 | 3.80 | |||
| Inventory Days | 0.00 | 0.00 | ||||||||||
| Days Payable | ||||||||||||
| Cash Conversion Cycle | 37.76 | 0.00 | 393.63 | 1,387.00 | 1,849.33 | 116.80 | 0.00 | 0.00 | 3.80 | |||
| Working Capital Days | 4,505.86 | -53.23 | 307.75 | 6,205.00 | 3,260.67 | 1,854.20 | 132.73 | 367.83 | 908.70 | |||
| ROCE % | -2.19% | -16.48% | 13.54% | 4.56% | -1.44% | -4.87% | 0.86% | 1.07% | -9.99% | -3.33% | -3.45% | -5.67% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | -0.57 | -0.38 | -0.40 | -1.18 | 0.11 |
| Diluted EPS (Rs.) | -0.57 | -0.38 | -0.40 | -1.18 | 0.11 |
| Cash EPS (Rs.) | -0.52 | -0.32 | -0.33 | -1.09 | 0.11 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 9.87 | 10.44 | 10.82 | 11.21 | 12.39 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 9.87 | 10.44 | 10.82 | 11.21 | 12.39 |
| Revenue From Operations / Share (Rs.) | 2.51 | 6.75 | 0.00 | 1.44 | 0.65 |
| PBDIT / Share (Rs.) | -0.51 | -0.30 | -0.32 | -1.10 | 0.14 |
| PBIT / Share (Rs.) | -0.55 | -0.36 | -0.38 | -1.19 | 0.14 |
| PBT / Share (Rs.) | -0.55 | -0.36 | -0.38 | -1.19 | 0.14 |
| Net Profit / Share (Rs.) | -0.56 | -0.37 | -0.39 | -1.18 | 0.11 |
| PBDIT Margin (%) | -20.58 | -4.52 | -6510.52 | -76.52 | 21.96 |
| PBIT Margin (%) | -22.25 | -5.33 | -7705.26 | -82.68 | 21.88 |
| PBT Margin (%) | -22.25 | -5.33 | -7705.26 | -82.68 | 21.88 |
| Net Profit Margin (%) | -22.61 | -5.61 | -7931.57 | -81.87 | 17.05 |
| Return on Networth / Equity (%) | -5.74 | -3.62 | -3.64 | -10.49 | 0.90 |
| Return on Capital Employeed (%) | -5.58 | -3.40 | -3.53 | -10.59 | 1.15 |
| Return On Assets (%) | -4.60 | -3.05 | -2.30 | -10.32 | 0.88 |
| Asset Turnover Ratio (%) | 0.20 | 0.45 | 0.00 | 0.11 | 0.05 |
| Current Ratio (X) | 3.69 | 4.73 | 2.09 | 44.05 | 15.06 |
| Quick Ratio (X) | 3.69 | 4.73 | 2.09 | 44.05 | 15.06 |
| Enterprise Value (Cr.) | 3.73 | 4.06 | 1.53 | 1.85 | 0.81 |
| EV / Net Operating Revenue (X) | 3.89 | 1.57 | 804.07 | 3.37 | 3.23 |
| EV / EBITDA (X) | -18.89 | -34.74 | -12.35 | -4.41 | 14.72 |
| MarketCap / Net Operating Revenue (X) | 3.89 | 1.57 | 1661.39 | 8.50 | 3.44 |
| Price / BV (X) | 0.98 | 1.02 | 0.76 | 1.09 | 0.18 |
| Price / Net Operating Revenue (X) | 3.89 | 1.57 | 2065.00 | 8.50 | 3.44 |
| EarningsYield | -0.05 | -0.03 | -0.04 | -0.09 | 0.04 |
After reviewing the key financial ratios for Elango Industries Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is -0.57. This value is below the healthy minimum of 5. It has decreased from -0.38 (Mar 24) to -0.57, marking a decrease of 0.19.
- For Diluted EPS (Rs.), as of Mar 25, the value is -0.57. This value is below the healthy minimum of 5. It has decreased from -0.38 (Mar 24) to -0.57, marking a decrease of 0.19.
- For Cash EPS (Rs.), as of Mar 25, the value is -0.52. This value is below the healthy minimum of 3. It has decreased from -0.32 (Mar 24) to -0.52, marking a decrease of 0.20.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 9.87. It has decreased from 10.44 (Mar 24) to 9.87, marking a decrease of 0.57.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 9.87. It has decreased from 10.44 (Mar 24) to 9.87, marking a decrease of 0.57.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 2.51. It has decreased from 6.75 (Mar 24) to 2.51, marking a decrease of 4.24.
- For PBDIT / Share (Rs.), as of Mar 25, the value is -0.51. This value is below the healthy minimum of 2. It has decreased from -0.30 (Mar 24) to -0.51, marking a decrease of 0.21.
- For PBIT / Share (Rs.), as of Mar 25, the value is -0.55. This value is below the healthy minimum of 0. It has decreased from -0.36 (Mar 24) to -0.55, marking a decrease of 0.19.
- For PBT / Share (Rs.), as of Mar 25, the value is -0.55. This value is below the healthy minimum of 0. It has decreased from -0.36 (Mar 24) to -0.55, marking a decrease of 0.19.
- For Net Profit / Share (Rs.), as of Mar 25, the value is -0.56. This value is below the healthy minimum of 2. It has decreased from -0.37 (Mar 24) to -0.56, marking a decrease of 0.19.
- For PBDIT Margin (%), as of Mar 25, the value is -20.58. This value is below the healthy minimum of 10. It has decreased from -4.52 (Mar 24) to -20.58, marking a decrease of 16.06.
- For PBIT Margin (%), as of Mar 25, the value is -22.25. This value is below the healthy minimum of 10. It has decreased from -5.33 (Mar 24) to -22.25, marking a decrease of 16.92.
- For PBT Margin (%), as of Mar 25, the value is -22.25. This value is below the healthy minimum of 10. It has decreased from -5.33 (Mar 24) to -22.25, marking a decrease of 16.92.
- For Net Profit Margin (%), as of Mar 25, the value is -22.61. This value is below the healthy minimum of 5. It has decreased from -5.61 (Mar 24) to -22.61, marking a decrease of 17.00.
- For Return on Networth / Equity (%), as of Mar 25, the value is -5.74. This value is below the healthy minimum of 15. It has decreased from -3.62 (Mar 24) to -5.74, marking a decrease of 2.12.
- For Return on Capital Employeed (%), as of Mar 25, the value is -5.58. This value is below the healthy minimum of 10. It has decreased from -3.40 (Mar 24) to -5.58, marking a decrease of 2.18.
- For Return On Assets (%), as of Mar 25, the value is -4.60. This value is below the healthy minimum of 5. It has decreased from -3.05 (Mar 24) to -4.60, marking a decrease of 1.55.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.20. It has decreased from 0.45 (Mar 24) to 0.20, marking a decrease of 0.25.
- For Current Ratio (X), as of Mar 25, the value is 3.69. This value exceeds the healthy maximum of 3. It has decreased from 4.73 (Mar 24) to 3.69, marking a decrease of 1.04.
- For Quick Ratio (X), as of Mar 25, the value is 3.69. This value exceeds the healthy maximum of 2. It has decreased from 4.73 (Mar 24) to 3.69, marking a decrease of 1.04.
- For Enterprise Value (Cr.), as of Mar 25, the value is 3.73. It has decreased from 4.06 (Mar 24) to 3.73, marking a decrease of 0.33.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 3.89. This value exceeds the healthy maximum of 3. It has increased from 1.57 (Mar 24) to 3.89, marking an increase of 2.32.
- For EV / EBITDA (X), as of Mar 25, the value is -18.89. This value is below the healthy minimum of 5. It has increased from -34.74 (Mar 24) to -18.89, marking an increase of 15.85.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 3.89. This value exceeds the healthy maximum of 3. It has increased from 1.57 (Mar 24) to 3.89, marking an increase of 2.32.
- For Price / BV (X), as of Mar 25, the value is 0.98. This value is below the healthy minimum of 1. It has decreased from 1.02 (Mar 24) to 0.98, marking a decrease of 0.04.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 3.89. This value exceeds the healthy maximum of 3. It has increased from 1.57 (Mar 24) to 3.89, marking an increase of 2.32.
- For EarningsYield, as of Mar 25, the value is -0.05. This value is below the healthy minimum of 5. It has decreased from -0.03 (Mar 24) to -0.05, marking a decrease of 0.02.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
Unable to fetch valid data for stock valuation.Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Elango Industries Ltd:
- Net Profit Margin: -22.61%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: -5.58% (Industry Average ROCE: 13.27%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: -5.74% (Industry Average ROE: 192.3%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 0
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 3.69
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 0 (Industry average Stock P/E: 85.28)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: -22.61%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Steel - Alloys/Special | No.5, Ranganathan Garden, 15th Main Road Extension, Chennai (Madras) Tamil Nadu 600040 | admin@kaveripower.com www.elangoindustries.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. S Elangovan | Managing Director |
| Mr. S A Premkumar | Director |
| Dr. M Ramasamy | Independent Director |
| Ms. Preethi Natarajan | Independent Director |
| Mrs. Asitha K | Independent Director |